Free Trial

Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives $16.77 Consensus Target Price from Brokerages

→ Kiss of death from Joe Biden (From Porter & Company) (Ad)

Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) have been given an average rating of "Moderate Buy" by the fourteen ratings firms that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $16.77.

A number of equities analysts have weighed in on the stock. Oppenheimer reduced their price objective on shares of Integral Ad Science from $25.00 to $20.00 and set an "outperform" rating for the company in a research report on Wednesday, February 28th. Morgan Stanley restated an "equal weight" rating and set a $12.00 price objective (down from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Benchmark restated a "hold" rating on shares of Integral Ad Science in a research report on Tuesday, May 7th. Craig Hallum reduced their price objective on shares of Integral Ad Science from $20.00 to $18.00 and set a "buy" rating for the company in a research report on Friday, May 10th. Finally, Raymond James reduced their price objective on shares of Integral Ad Science from $16.00 to $13.00 and set an "outperform" rating for the company in a research report on Friday, May 10th.

View Our Latest Stock Analysis on IAS


Insider Activity at Integral Ad Science

In related news, CAO Alexis Gil II sold 3,177 shares of the company's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the sale, the chief accounting officer now owns 120,195 shares of the company's stock, valued at $1,230,796.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Integral Ad Science news, CFO Tania Secor sold 8,929 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $9.71, for a total transaction of $86,700.59. Following the completion of the transaction, the chief financial officer now owns 221,959 shares of the company's stock, valued at $2,155,221.89. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Alexis Gil II sold 3,177 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $10.24, for a total transaction of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares of the company's stock, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. Over the last quarter, insiders sold 75,126 shares of company stock valued at $749,707. 2.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of IAS. Skandinaviska Enskilda Banken AB publ acquired a new position in Integral Ad Science during the 3rd quarter worth $58,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Integral Ad Science during the third quarter worth about $62,000. Ameritas Investment Partners Inc. increased its stake in shares of Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company's stock worth $67,000 after buying an additional 1,924 shares during the period. Amalgamated Bank raised its holdings in Integral Ad Science by 19.9% in the third quarter. Amalgamated Bank now owns 6,951 shares of the company's stock valued at $83,000 after acquiring an additional 1,156 shares in the last quarter. Finally, Sherbrooke Park Advisers LLC purchased a new position in Integral Ad Science in the third quarter worth approximately $140,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Stock Performance

Shares of IAS traded down $0.01 during trading hours on Friday, hitting $9.80. The stock had a trading volume of 786,338 shares, compared to its average volume of 2,308,013. The company has a debt-to-equity ratio of 0.13, a quick ratio of 4.32 and a current ratio of 4.32. The firm has a 50-day moving average price of $9.61 and a 200 day moving average price of $12.72. Integral Ad Science has a fifty-two week low of $7.98 and a fifty-two week high of $20.88. The firm has a market capitalization of $1.57 billion, a price-to-earnings ratio of 980.98, a PEG ratio of 1.84 and a beta of 1.58.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Integral Ad Science had a net margin of 0.59% and a return on equity of 0.32%. The firm had revenue of $114.50 million during the quarter, compared to analysts' expectations of $112.12 million. During the same period in the previous year, the business posted $0.02 EPS. The business's revenue was up 7.9% compared to the same quarter last year. As a group, research analysts anticipate that Integral Ad Science will post 0.22 EPS for the current year.

Integral Ad Science Company Profile

(Get Free Report

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

See Also

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Integral Ad Science right now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: